Editorial: The impact of microbially modified metabolites associated with obesity and bariatric surgery on anti-tumor immunity
Front Immunol
.
2023 Sep 12:14:1278862.
doi: 10.3389/fimmu.2023.1278862.
eCollection 2023.
Authors
Yan Guo
1
,
Lin Qi
2
,
Ouyang Chen
3
,
Sharat Chandra
3
,
Dajin Zou
4
Affiliations
1
Department of Endocrinology, Changhai Hospital, Naval Medical University, Shanghai, China.
2
Hunan Key Laboratory of Tumour Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
3
Department of Cell Biology, Duke University Medical Center, Durham, NC, United States.
4
Department of Endocrinology and Metabolism, Punan Branch, Renji Hospital, Jiaotong University, Shanghai, China.
PMID:
37771592
PMCID:
PMC10523303
DOI:
10.3389/fimmu.2023.1278862
No abstract available
Keywords:
antitumor immunity; bariatric surgery; gut microbiota; metabolites; obesity.
Publication types
Editorial
Grants and funding
This study was supported by the Natural Science Foundation of Shanghai (20ZR1456600).